These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3496165)

  • 1. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides.
    Bahr GM; Chedid LA; Behbehani K
    Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.
    Galelli A; Le Garrec Y; Chedid L; Lefrancier P; Derrien M; Level M
    Infect Immun; 1980 Apr; 28(1):1-5. PubMed ID: 6769814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
    Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
    Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.
    Byars NE
    Infect Immun; 1984 May; 44(2):344-50. PubMed ID: 6609127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H; Koga T
    Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
    Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
    Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
    Löwy I; Leclerc C; Chedid L
    Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of macrophage migration by muramyl peptides.
    Nagao S; Tanaka A; Yamamoto Y; Koga T; Onoue K; Shiba T; Kusumoto K; Kotani S
    Infect Immun; 1979 May; 24(2):308-12. PubMed ID: 457276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony-stimulating activity induced by synthetic muramyl peptides: variation with chemical structure and association with anti-infectious activity.
    Galelli A; Lefrancier P; Chedid L
    Infect Immun; 1984 Nov; 46(2):495-500. PubMed ID: 6334030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
    Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
    Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of B-cell stimulation by muramyl dipeptide through a mechanism not involving interleukin 1 or increased Ca2+ mobilization or protein kinase C activation.
    Dziarski R
    Cell Immunol; 1988 Jan; 111(1):10-27. PubMed ID: 2448043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
    Leclerc C; Chedid L
    Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone.
    Riveau G; Hosmalin A; Carelli C; Lefrancier P; Chedid L
    J Leukoc Biol; 1988 Nov; 44(5):448-54. PubMed ID: 3053952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
    Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
    Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1, a mediator of immunoadjuvant peptidoglycans.
    Guenounou M; Vacheron F; Nauciel C
    Comp Immunol Microbiol Infect Dis; 1985; 8(3-4):273-84. PubMed ID: 2868825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
    Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.